Layrek Clinical Research | Tulsa, OK
Research site
Site insights
Top conditions
Top treatments
BMS-986278
Lunsekimig
PF-07275315
Curious how this site stacks up to its peers?
Data sourced from clinicaltrials.gov
Active trials
4 of 4 total trials
The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in participants with Idiopathic Pulmonary Fibrosis.
Active, not recruiting
Idiopathic Pulmonary Fibrosis
Drug: BMS-986278
Drug: BMS-986278 Placebo
The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.
Active, not recruiting
Progressive Pulmonary Fibrosis
Drug: BMS-986278 Placebo
Drug: BMS-986278
The purpose of this clinical trial is to learn about the safety and effects of the study medicine (called PF-07275315) for the potential treatment of...
Enrolling
Asthma
Other: Placebo
Drug: PF-07275315
This is a parallel, Phase 2/Phase 3, 3-arm study to investigate the efficacy, safety, and tolerability of subcutaneous (SC) treatment with lunsekimig...
Enrolling
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Lunsekimig
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2026 Veeva Systems